This release is mediated by ADAMTS-13, so that ADAMTS-13 deficiency is associated with occlusive diseases such as myocardial infarction and stroke, and its low activity is a predictor of unfavorable results in patients with ischemic stroke undergoing endovascular therapy [109]. This evidence concerns the gene ADAMTS13 and ischemic stroke.